These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20966878)

  • 1. Chemometric studies on natural products as potential inhibitors of the NADH oxidase from Trypanosoma cruzi using the VolSurf approach.
    Scotti L; Ferreira EI; Silva MS; Scotti MT
    Molecules; 2010 Oct; 15(10):7363-77. PubMed ID: 20966878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D QSAR studies on binding affinities of coumarin natural products for glycosomal GAPDH of Trypanosoma cruzi.
    Menezes IR; Lopes JC; Montanari CA; Oliva G; Pavão F; Castilho MS; Vieira PC; Pupo MT
    J Comput Aided Mol Des; 2003; 17(5-6):277-90. PubMed ID: 14635721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel aryl β-aminocarbonyl derivatives as inhibitors of Trypanosoma cruzi trypanothione reductase: binding mode revised by docking and GRIND2-based 3D-QSAR procedures.
    de Paula da Silva CH; Bernardes LS; da Silva VB; Zani CL; Carvalho I
    J Biomol Struct Dyn; 2012; 29(6):702-16. PubMed ID: 22546000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational and Investigative Study of Flavonoids Active Against Typanosoma cruzi and Leishmania spp.
    Ribeiro FF; Junior FJ; da Silva MS; Scotti MT; Scotti L
    Nat Prod Commun; 2015 Jun; 10(6):917-20. PubMed ID: 26197515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico identification and evaluation of new Trypanosoma cruzi trypanothione reductase (TcTR) inhibitors obtained from natural products database of the Bahia semi-arid region (NatProDB).
    da Paixão VG; Pita SSDR
    Comput Biol Chem; 2019 Apr; 79():36-47. PubMed ID: 30710804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New spermine and spermidine derivatives as potent inhibitors of Trypanosoma cruzi trypanothione reductase.
    Bonnet B; Soullez D; Davioud-Charvet E; Landry V; Horvath D; Sergheraert C
    Bioorg Med Chem; 1997 Jul; 5(7):1249-56. PubMed ID: 9377084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-dependent 4D-QSAR analysis of peptidemimetic inhibitors of Trypanosoma cruzi trypanothione reductase with receptor-based alignment.
    da Rocha Pita SS; Albuquerque MG; Rodrigues CR; Castro HC; Hopfinger AJ
    Chem Biol Drug Des; 2012 May; 79(5):740-8. PubMed ID: 22269140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indazoles: a new top seed structure in the search of efficient drugs against Trypanosoma cruzi.
    Aguilera-Venegas B; Olea-Azar C; Arán VJ; Speisky H
    Future Med Chem; 2013 Oct; 5(15):1843-59. PubMed ID: 24144415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
    Beltran-Hortelano I; Perez-Silanes S; Galiano S
    Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the mitochondrial NADH-oxidase (NADH-coenzyme Q oxido-reductase) enzyme system by flavonoids: a structure-activity study.
    Hodnick WF; Bohmont CW; Capps C; Pardini RS
    Biochem Pharmacol; 1987 Sep; 36(17):2873-4. PubMed ID: 3632714
    [No Abstract]   [Full Text] [Related]  

  • 11. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
    Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
    Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
    Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD
    J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemometric studies on potential larvicidal compounds against Aedes aegypti.
    Scotti L; Scotti MT; Silva VB; Santos SR; Cavalcanti SC; Mendonça FJ
    Med Chem; 2014 Mar; 10(2):201-10. PubMed ID: 23676010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships in 2-aminodiphenylsulfides against trypanothione reductase from Trypanosoma cruzi.
    Girault S; Davioud-Charvet E; Salmon L; Berecibar A; Debreu MA; Sergheraert C
    Bioorg Med Chem Lett; 1998 May; 8(10):1175-80. PubMed ID: 9871730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential trypanothione reductase inhibitors among commercially available β-carboline derivatives using chemical space, lead-like and drug-like filters, pharmacophore models and molecular docking.
    Rodríguez-Becerra J; Cáceres-Jensen L; Hernández-Ramos J; Barrientos L
    Mol Divers; 2017 Aug; 21(3):697-711. PubMed ID: 28656524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.
    Pauli I; Ferreira LG; de Souza ML; Oliva G; Ferreira RS; Dessoy MA; Slafer BW; Dias LC; Andricopulo AD
    Future Med Chem; 2017 May; 9(7):641-657. PubMed ID: 28509592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutic targets for drug design against Trypanosoma cruzi, advances and perspectives.
    Rivera G; Bocanegra-García V; Ordaz-Pichardo C; Nogueda-Torres B; Monge A
    Curr Med Chem; 2009; 16(25):3286-93. PubMed ID: 19548870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi trypanothione reductase inhibitors: phenothiazines and related compounds modify experimental Chagas' disease evolution.
    Rivarola HW; Paglini-Oliva PA
    Curr Drug Targets Cardiovasc Haematol Disord; 2002 Jun; 2(1):43-52. PubMed ID: 12769656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemotherapy of chagas' disease: an overview.
    Paulino M; Iribarne F; Dubin M; Aguilera-Morales S; Tapia O; Stoppani AO
    Mini Rev Med Chem; 2005 May; 5(5):499-519. PubMed ID: 15892691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase.
    Arias DG; Herrera FE; Garay AS; Rodrigues D; Forastieri PS; Luna LE; Bürgi MD; Prieto C; Iglesias AA; Cravero RM; Guerrero SA
    Eur J Med Chem; 2017 Jan; 125():1088-1097. PubMed ID: 27810595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.